| Pre-pandemic (n = 25) | In-pandemic (n = 25) | P value |
---|---|---|---|
Age in years (mean ± SD) | 44.1 ± 2.68 | 42.2 ± 4.42 | 0.068 |
Median (range, years) | 44 (39–51) | 43 (32–53) |  |
BMI (kg/m2)) (mean ± SD) | 23.7 ± 5.27 | 23.3 ± 5.80 | 0.528 |
Median (range) | 21.9 (15.7–41.9) | 22 (18.3–46.5) |  |
Gravity (No.) (mean ± SD) | 1.6 ± 1.29 | 2.1 ± 1.9 | 0.356 |
Median (range, No.) | 2 (0–5) | 2 (0–7) |  |
Parity (No.) (mean ± SD) | 1.3 ± 1.06 | 1.4 ± 1.23 | 0.792 |
Median (range, No.) | 1 (0–4) | 1 (0–5) |  |
Menstrual cycle: | |||
 P/O/S/M/A/unclear | 2/2/16/1/2/2 | 1/1/14/0/2/7 | 0.519 |
 Hormonal therapy: yes/no/unknown | 7/18/0 | 12/13/0 | 0.244 |
 Smoking: yes/no | 11/14 | 7/18 | 0.377 |
Coexisting diseases: | |||
 uterine myoma: yes/no | 24/1 | 19/6 | 0.098 |
 endometriosis: yes/no | 4/21 | 3/22 | 1.000 |
 adenomyosis: yes/no | 1/24 | 4/21 | 0.349 |
 none: yes/no | 1/24 | 4/21 | 0.349 |
*Surgical procedures: | |||
 TLH: yes/no | 19/6 | 19/6 | 1.000 |
 BTR: yes/no | 14/11 | 14/11 | 1.000 |
 RASH: yes/no | 6/19 | 6/19 | 1.000 |
 LSCP: yes/no | 1/24 | 0/25 | 1.000 |
*Indication of surgery: | |||
 CIN2-3/myoma/MBT/PU/ | 6/18/2/1/1/4 | 5/15/0/0/0/1/7 | - |
 SCC/AIS/hypermenorrhea |  |  |  |